title: Time for a reassessment of the use of Kava in anxiety?
authors.forename: J
authors.initials: J
authors.lastname: Sarris
authors.forename: J
authors.initials: J
authors.lastname: Adams
authors.forename: J L
authors.initials: JL
authors.lastname: Wardle
mesh_terms: D000383:Agriculture / Q000191:economics; D001007:Anxiety / Q000188:drug therapy*; D002170:Canada; D004335:Drug and Narcotic Control / Q000191:economics; D005062:European Union; D006801:Humans; D020901:Kava / Q000009:adverse effects; D008517:Phytotherapy / Q000009:adverse effects; D028321:Plant Preparations / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D006113:United Kingdom
chemical_list: D028321:Plant Preparations